Entact Bio, Inc. — Form D/A
Entact Bio, Inc. of Watertown, MA, a company, filed a Form D amendment with the SEC on 2024-05-15. The offering totals $40.3M, of which $40.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-15
- Form: D/A
- Accession: 0002008244-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.3M
- Amount sold: $40.3M
- Investors: 7
- Date of first sale: 2024-01-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-503956
Issuer
- Name: Entact Bio, Inc.
- CIK: 0002008244
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 65 Grove Street, Suite 303, Watertown, MA, 02472
- Phone: 617-909-7579
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Anna French | Director | Watertown, MA |
| Richard Gaster | Director | Waltham, MA |
| Alon Lazarus | Director | Cambridge, MA |
| Victoria Richon | Director | Watertown, MA |
| Andrew Sinclair | Director | Watertown, MA |
| Owen Smith | Director | Watertown, MA |
| Victoria Richon | Executive Officer | Watertown, MA |
| Andrew Sinclair | Related Person | Watertown, MA |
| Anna French | Related Person | Watertown, MA |
| Richard Gaster | Related Person | Waltham, MA |
| Victoria Richon | Related Person | Watertown, MA |
| Owen Smith | Related Person | Watertown, MA |
| PINI ORBACH | Related Person | Watertown, MA |
Other filings by this issuer (2)
More